Abdullah, Wahida B.

HRN: 21-29-91  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2022
AMPICILLIN 1GM (VIAL)
05/05/2022
05/11/2022
IV
1g
Q6
PROM
Waiting Final Action 
06/06/2023
CO-AMOXICLAV 625MG (TAB)
06/18/2023
06/25/2023
ORAL
625 Mg
BID
Septicemia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: